Home › NDC Lookup › RxCUI directory › RxCUI 902624

Dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant] — RxCUI 902624

RxNorm drug concept · Semantic branded drug
RxCUI 902624 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI902624
Official nameDexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDexilant 30 MG Delayed Release Oral Capsule
FDA products mapped2
Package NDCs mapped14
Reported Medicaid activity (SDUD)38,916 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dexlansoprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Good news — you can take dexlansoprazole with or without food, whichever is easier for you. Unlike some older acid-suppressing medicines, there's no requirement to time it before m...
  • Can I take this medicine with food, or do I need to take it on an empty stomach?
  • Yes, absolutely. You can open the capsule and sprinkle the small pellets or granules onto one tablespoon of applesauce, then swallow the mixture right away — just don't chew the pe...
  • I have trouble swallowing capsules. Is there another way to take this?
📖 Read our full Dexlansoprazole guide →

🕸️ Concept Web — How Dexlansoprazole 30 MG Delayed Release Oral Capsu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant] RxCUI 902624

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dexlansoprazole 816346
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dexilant 902621
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dexlansoprazole Delayed Release Oral Capsule 833203
    • Dexlansoprazole Oral Product 1157800
    • Dexlansoprazole Pill 1157801
    • Dexlansoprazole Delayed Release Oral Capsule [Dexilant] 902623
    • Dexilant Oral Product 1175841
    • Dexilant Pill 1175842
    • Delayed Release Oral Capsule 316995
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Dexlansoprazole 30 MG [Dexilant] SBDC · 902622
  • Dexlansoprazole Delayed Release Oral Capsule [Dexilant] SBDF · 902623
  • Dexilant Oral Product SBDG · 1175841
  • Dexilant Pill SBDG · 1175842
  • Dexilant BN · 902621

📦 FDA Products & Package NDCs

2 products · 14 package NDCs
14 package NDCs map to RxCUI 902624 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64764-0171-00 7 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-00) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0171-01 5 BLISTER PACK in 1 TRAY (64764-171-01) / 4 CAPSULE, DELAYE... Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0171-03 1 BOTTLE in 1 CARTON (64764-171-03) / 5 CAPSULE, DELAYED RE... Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0171-11 10 BLISTER PACK in 1 CARTON (64764-171-11) / 10 CAPSULE, DE... Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0171-19 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-19) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0171-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-30) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0171-90 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-90) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0175-00 7 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-00) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0175-01 5 BLISTER PACK in 1 TRAY (64764-175-01) / 4 CAPSULE, DELAYE... Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0175-02 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-02) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0175-11 10 BLISTER PACK in 1 CARTON (64764-175-11) / 10 CAPSULE, DE... Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0175-19 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-19) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0175-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-30) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
64764-0175-90 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-90) Dexilant Takeda Pharmaceuticals America, Inc. 2010-04-12
Observed labelers: Takeda Pharmaceuticals America, Inc. (14) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.